Why Are patients With Heart Failure and Preserved Ejection Fraction Hospitalized? Data From I-PRESERVE

被引：0
|
作者：
Carson, Peter [1 ]
Anand, Inder [2 ]
Win, Sithu [2 ]
Zile, Michael [3 ,4 ]
Haas, Markus [5 ]
Little, William [6 ]
Miller, Alan [7 ]
Lopez-Sendon, Jose [8 ]
Teerlink, John [9 ,10 ]
White, Michel [11 ]
Komajda, Michel [12 ]
McKelvie, Robert S. [13 ]
McMurray, John J. [14 ]
Massie, Barry [9 ,10 ]
机构：
[1] Washington VA Med Cntr, Washington, DC USA
[2] Minneapolis VAMC, Cardiol, Minneapolis, MN USA
[3] Charleston VAMC, Cardiol, Charleston, SC USA
[4] MUSC, Charleston, SC USA
[5] Theresienkrankenhaus, Mannheim, Germany
[6] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA
[7] Univ Florida Shands, Jacksonville, FL USA
[8] Hosp Univ LePaz, Madrid, Spain
[9] Univ Calif San Francisco, San Francisco, CA 94143 USA
[10] San Francisco VA Med Ctr, San Francisco, CA USA
[11] Montreal Heart Cntr, Montreal, PQ, Canada
[12] Univ Paris, Pitie Salpetriere Hosp, F-75252 Paris, France
[13] McMaster Univ, Hamilton Hlth Sci, Hamilton, ON, Canada
[14] Univ Glasgow, British Heart Fdn Glasgow Cardiovasc Rsch Cntr, Glasgow, Lanark, Scotland
来源：
CIRCULATION | 2013年 / 128卷 / 22期
关键词：
Heart failure; Ejection fraction;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
15844
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Anaemia is associated with poor outcome in patients with heart failure and preserved ejection fraction (HF PEF). Findings from the Irbesartan in Heart Failure with Preserved Systolic Function Trial (I-PRESERVE)
    Komajda, Michel
    McKelvie, Robert S.
    McMurray, John J.
    Zile, Michael R.
    Donovan, Mark
    Ptaszynska, Agatha
    Massie, Barry M.
    Carson, Peter
    CIRCULATION, 2007, 116 (16) : 551 - 551
  • [22] What Have We Learned About Patients With Heart Failure and Preserved Ejection Fraction From DIG-PEF, CHARM-Preserved, and I-PRESERVE?
    Campbell, Ross T.
    Jhund, Pardeep S.
    Castagno, Davide
    Hawkins, Nathaniel M.
    Petrie, Mark C.
    McMurray, John J. V.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (23) : 2349 - 2356
  • [23] The Prognostic Value of Insulin-like Growth Factor-Binding Protein 7 in Patients With Heart Failure and Preserved Ejection Fraction: Results From Irbesartan in Heart Failure and Preserved Ejection Fraction (I-PRESERVE) Trial
    Gandhi, Parul U.
    Chow, Sheryl L.
    Rector, Thomas S.
    Krum, Henry
    Gaggin, Hanna K.
    McMurray, John J.
    Zile, Michael
    Komajda, Michel
    McKelvie, Robert S.
    Carson, Peter E.
    Januzzi, James L.
    Anand, Inder S.
    CIRCULATION, 2015, 132
  • [24] Risk of Clinical Outcomes and Baseline Atrial Fibrillation: Irbesartan in Heart Failure With Preserved Ejection Fraction (I-PRESERVE) Trial
    Oluleye, Oludamilola
    Win, Sithu
    Rector, Thomas
    Komadja, Michel
    Zile, Michael
    Mckelvie, Robert
    McMurray, John
    Massie, Barry
    Carson, Peter
    Anand, Inderjit
    CIRCULATION, 2013, 128 (22)
  • [25] Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials
    Abdul-Rahim, Azmil H.
    Perez, Ana-Cristina
    MacIsaac, Rachael L.
    Jhund, Pardeep S.
    Claggett, Brian L.
    Carson, Peter E.
    Komajda, Michel
    McKelvie, Robert S.
    Zile, Michael R.
    Swedberg, Karl
    Yusuf, Salim
    Pfeffer, Marc A.
    Solomon, Scott D.
    Lip, Gregory Y. H.
    Lees, Kennedy R.
    McMurray, John J. V.
    EUROPEAN HEART JOURNAL, 2017, 38 (10) : 742 - 750
  • [26] I-PRESERVE SUB-STUDY: PLASMA COLLAGEN MARKERS IN THE PREDICTION OF DEATH AND HOSPITALISATION IN PATIENTS WITH HEART FAILURE AND PRESERVED EJECTION FRACTION
    Schneider, Hans G.
    Krum, Henry
    Elsik, Maros
    Ptaszynska, Agata
    Black, Marion
    Anand, Inder
    Carson, Peter
    Massie, Barry
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S337 - S337
  • [27] Relation of Peripheral Collagen Markers to Death and Hospitalization in Patients With Heart Failure and Preserved Ejection Fraction Results of the I-PRESERVE Collagen Substudy
    Krum, Henry
    Elsik, Maros
    Schneider, Hans G.
    Ptaszynska, Agata
    Black, Marion
    Carson, Peter E.
    Komajda, Michel
    Massie, Barry M.
    McKelvie, Robert S.
    McMurray, John J.
    Zile, Michael R.
    Anand, Inder S.
    CIRCULATION-HEART FAILURE, 2011, 4 (05) : 561 - 568
  • [28] Heart Rate and Outcomes in Hospitalized Patients With Heart Failure With Preserved Ejection Fraction
    Lam, Phillip H.
    Dooley, Daniel J.
    Deedwania, Prakash
    Singh, Steven N.
    Bhatt, Deepak L.
    Morgan, Charity J.
    Butler, Javed
    Mohammed, Selma F.
    Wu, Wen-Chih
    Panjrath, Gurusher
    Zile, Michael R.
    White, Michel
    Arundel, Cherinne
    Love, Thomas E.
    Blackman, Marc R.
    Allman, Richard M.
    Aronow, Wilbert S.
    Anker, Stefan D.
    Fonarow, Gregg C.
    Ahmed, Ali
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (15) : 1861 - 1871
  • [29] Which formula for estimating glomerular filtration rate is the better predictor of outcomes in heart failure with preserved ejection fraction? An analysis from the I-Preserve trial
    Pozzi, A.
    Jhund, P. S.
    Damman, K.
    Massie, B. M.
    Carson, P.
    Komajda, M. R.
    Mckelvie, R.
    Zile, M. R.
    Anand, I. S.
    Mcmurray, J. J. V.
    EUROPEAN HEART JOURNAL, 2014, 35 : 2 - 2
  • [30] Prognostic value of baseline NT-proBNP and its interactions with irbesartan treatment in patients with heart failure and preserved ejection fraction: Findings from the I-PRESERVE trial
    Anand, I. S.
    Rector, T. S.
    Cleland, J. G.
    Kckelvie, R. S.
    Persson, H.
    Mcmurray, J. J.
    Zile, M.
    Komajda, M.
    Massie, B.
    Carson, P.
    EUROPEAN HEART JOURNAL, 2011, 32 : 495 - 495
12345